Is it time to tailor treatments in androgen receptor positive salivary gland cancers?

Competing Interests: Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: P.B. reported participation to advisory board or conference honoraria, outside the submitted work from: Merck, Sanofi, Merck Sharp & Dohme, SunPharma, Angelini, AstraZeneca, Bristol-Myers Squibb, Helsinn, Roche, GSK. A.B.reported participation for advisory, paid public speech, research funds, outside the submitted work from: Janssen Cilag, Ipsen, Novartis AAA, Astellas, Amgen, HRA.